The University of Chicago Header Logo

Connection

Mary Elizabeth Strek to Male

Back to Details
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Male.
Mary Elizabeth Strek
Connection Strength
0.886
Male
  1. The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry. Respir Res. 2024 Jun 21; 25(1):255.
    View in: PubMed
    Score: 0.041
  2. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
    View in: PubMed
    Score: 0.037
  3. Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases. Chest. 2021 07; 160(1):209-218.
    View in: PubMed
    Score: 0.032
  4. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).
    View in: PubMed
    Score: 0.027
  5. CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AJR Am J Roentgenol. 2018 May; 210(5):1034-1041.
    View in: PubMed
    Score: 0.026
  6. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.
    View in: PubMed
    Score: 0.026
  7. De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 09; 152(3):683-685.
    View in: PubMed
    Score: 0.025
  8. CT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017 Dec; 27(12):5127-5135.
    View in: PubMed
    Score: 0.025
  9. CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.
    View in: PubMed
    Score: 0.025
  10. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
    View in: PubMed
    Score: 0.024
  11. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.
    View in: PubMed
    Score: 0.023
  12. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
    View in: PubMed
    Score: 0.023
  13. Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.
    View in: PubMed
    Score: 0.023
  14. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest. 2012 Jul; 142(1):159-167.
    View in: PubMed
    Score: 0.018
  15. Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011 Nov; 140(5):1292-1299.
    View in: PubMed
    Score: 0.016
  16. Comprehensive assessment of complete blood count as a prognostic biomarker in interstitial lung diseases. Respir Med. 2026 Oct; 262:109086.
    View in: PubMed
    Score: 0.012
  17. Molecular endotypes predict differential response to immunosuppressant therapy in non-idiopathic pulmonary fibrosis interstitial lung disease. Am J Respir Crit Care Med. 2026 Apr 01; 212(4):768-777.
    View in: PubMed
    Score: 0.011
  18. Radiologic Features of Airways Disease Are Associated With Interstitial Lung Abnormality Progression. Respir Care. 2026 Apr; 71(4):390-396.
    View in: PubMed
    Score: 0.011
  19. Association of Recovery Rate From Exertional Desaturation With Disease Progression and Mortality Risk in Patients With Fibrotic Interstitial Lung Disease. Chest. 2026 Jun; 169(6):1588-1598.
    View in: PubMed
    Score: 0.011
  20. Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2025 10; 211(10):1867-1875.
    View in: PubMed
    Score: 0.011
  21. A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2025 10; 211(10):1785-1793.
    View in: PubMed
    Score: 0.011
  22. Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 10; 211(10):1823-1834.
    View in: PubMed
    Score: 0.011
  23. Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 08; 211(8):1452-1462.
    View in: PubMed
    Score: 0.011
  24. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
    View in: PubMed
    Score: 0.010
  25. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 09 01; 210(5):639-647.
    View in: PubMed
    Score: 0.010
  26. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 08 15; 210(4):444-454.
    View in: PubMed
    Score: 0.010
  27. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts. Am J Respir Crit Care Med. 2024 08 15; 210(4):455-464.
    View in: PubMed
    Score: 0.010
  28. Hypersensitivity Pneumonitis on Thin-Section Chest CT Scans: Diagnostic Performance of the ATS/JRS/ALAT versus ACCP Imaging Guidelines. Radiol Cardiothorac Imaging. 2024 08; 6(4):e230068.
    View in: PubMed
    Score: 0.010
  29. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1111-1120.
    View in: PubMed
    Score: 0.010
  30. Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. Am J Respir Crit Care Med. 2024 05 01; 209(9):1121-1131.
    View in: PubMed
    Score: 0.010
  31. Risk Factors for Hospital Readmission in Patients With Interstitial Lung Disease. Respir Care. 2024 04 22; 69(5):586-594.
    View in: PubMed
    Score: 0.010
  32. A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis. J Heart Lung Transplant. 2024 07; 43(7):1174-1182.
    View in: PubMed
    Score: 0.010
  33. Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. Chest. 2024 03; 165(3):621-631.
    View in: PubMed
    Score: 0.010
  34. Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis. Respir Med. 2023 10; 217:107330.
    View in: PubMed
    Score: 0.009
  35. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2023 08 01; 325(2):L233-L243.
    View in: PubMed
    Score: 0.009
  36. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Respir Res. 2023 May 31; 24(1):141.
    View in: PubMed
    Score: 0.009
  37. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 05; 163(5):1156-1165.
    View in: PubMed
    Score: 0.009
  38. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022 08; 27(8):635-644.
    View in: PubMed
    Score: 0.009
  39. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
    View in: PubMed
    Score: 0.009
  40. Hospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021 Sep 30; 22(1):257.
    View in: PubMed
    Score: 0.008
  41. Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208.
    View in: PubMed
    Score: 0.008
  42. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 02; 161(2):470-482.
    View in: PubMed
    Score: 0.008
  43. Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med. 2001 Jan; 95(1):1-4.
    View in: PubMed
    Score: 0.008
  44. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
    View in: PubMed
    Score: 0.008
  45. Gender equity in interstitial lung disease. Lancet Respir Med. 2020 09; 8(9):842-843.
    View in: PubMed
    Score: 0.008
  46. CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.
    View in: PubMed
    Score: 0.008
  47. Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.
    View in: PubMed
    Score: 0.008
  48. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574.
    View in: PubMed
    Score: 0.008
  49. Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.
    View in: PubMed
    Score: 0.007
  50. Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.
    View in: PubMed
    Score: 0.007
  51. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 07 15; 200(2):199-208.
    View in: PubMed
    Score: 0.007
  52. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723.
    View in: PubMed
    Score: 0.007
  53. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
    View in: PubMed
    Score: 0.007
  54. Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).
    View in: PubMed
    Score: 0.007
  55. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.
    View in: PubMed
    Score: 0.007
  56. Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. Respir Med. 2019 01; 146:23-27.
    View in: PubMed
    Score: 0.007
  57. Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.
    View in: PubMed
    Score: 0.007
  58. N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC Pulm Med. 2018 Feb 08; 18(1):30.
    View in: PubMed
    Score: 0.007
  59. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
    View in: PubMed
    Score: 0.006
  60. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov; 44(11):1612-1618.
    View in: PubMed
    Score: 0.006
  61. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
    View in: PubMed
    Score: 0.006
  62. Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med. 2017 Jul; 141(7):960-969.
    View in: PubMed
    Score: 0.006
  63. Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017 02; 123:56-62.
    View in: PubMed
    Score: 0.006
  64. Response. Chest. 2016 Feb; 149(2):600-601.
    View in: PubMed
    Score: 0.006
  65. Mechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis. Am J Physiol. 1996 Jan; 270(1 Pt 1):L133-40.
    View in: PubMed
    Score: 0.006
  66. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1475-82.
    View in: PubMed
    Score: 0.006
  67. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Nov 21; 15:147.
    View in: PubMed
    Score: 0.006
  68. Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2015 Sep; 148(3):692-700.
    View in: PubMed
    Score: 0.006
  69. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92.
    View in: PubMed
    Score: 0.005
  70. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
    View in: PubMed
    Score: 0.005
  71. Physiologic significance of epithelial removal on guinea pig tracheal smooth muscle response to acetylcholine and serotonin. Am Rev Respir Dis. 1993 Jun; 147(6 Pt 1):1477-82.
    View in: PubMed
    Score: 0.005
  72. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013 May 07; 158(9):641-9.
    View in: PubMed
    Score: 0.005
  73. Effect of mode of activation of human eosinophils on tracheal smooth muscle contraction in guinea pigs. Am J Physiol. 1993 May; 264(5 Pt 1):L475-81.
    View in: PubMed
    Score: 0.005
  74. Barriers to optimal palliative care of lung transplant candidates. Chest. 2013 Mar; 143(3):736-743.
    View in: PubMed
    Score: 0.005
  75. Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2. Am Rev Respir Dis. 1992 Jun; 145(6):1463-8.
    View in: PubMed
    Score: 0.004
  76. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2012 Feb; 39(2):344-51.
    View in: PubMed
    Score: 0.004
  77. Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol. 2009 Aug; 15(5):254-5.
    View in: PubMed
    Score: 0.004
  78. Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.
    View in: PubMed
    Score: 0.003
  79. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am J Physiol. 1993 Sep; 265(3 Pt 1):L301-7.
    View in: PubMed
    Score: 0.001
  80. Effects of PAF on isolated rat airways perfused with blood-free solution. Am J Physiol. 1991 Apr; 260(4 Pt 1):L260-7.
    View in: PubMed
    Score: 0.001
  81. Longitudinal distribution of canine respiratory heat and water exchanges. J Appl Physiol (1985). 1989 Jun; 66(6):2788-98.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.